Skip to main content

Peer Review reports

From: Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial

Original Submission
16 Nov 2016 Submitted Original manuscript
1 Jan 2017 Reviewed Reviewer Report - Gianfranco Di Gennaro
23 Jan 2017 Reviewed Reviewer Report - Franco Schiavon
19 Feb 2017 Author responded Author comments - Rona Smith
Resubmission - Version 2
19 Feb 2017 Submitted Manuscript version 2
20 Feb 2017 Editorially accepted
7 Mar 2017 Article published 10.1186/s13063-017-1857-z

You can find further information about peer review here.

Back to article page